Back

Recommendations for Primary Prevention of Skin Melanoma

Tasa, T.; Puustusmaa, M.; Tonisson, N.; Kolk, B.; Padrik, P.

2020-08-31 genetic and genomic medicine
10.1101/2020.08.25.20181610 medRxiv
Show abstract

Melanoma (MEL) is an aggressive form of skin cancer, causing over 60,000 deaths every year and it is considered one of the fastest-growing cancer forms. Genome-wide association studies have identified numerous genetic variants (SNPs) independently associated with MEL. The effects of such SNPs can be combined into a single polygenic risk score (PRS). Stratification of individuals according to PRS could be introduced to the primary prevention of melanoma. Our aim was to combine PRS with health behavior recommendations to develop a personalized recommendation for primary prevention of melanoma. Previously published PRS models for predicting the risk of melanoma were collected from the literature. Models were validated on the UK Biobank dataset consisting of a total of 487,410 quality-controlled genotypes with 3791 prevalent and 2345 incident cases. The best performing sex-specific models were selected based on the AUC in prevalent data and independently validated on an independent UKBB incident dataset for females and males separately. The best performing model included 28 SNPs. The C-index of the best performing model in the dataset was 0.59 (0.009) and hazard ratio (HR) per unit of PRS was 1.38 (standard error of log (HR) = 0.03) for both males and females. We performed absolute risk simulations on the Estonian population and developed individual risk-based clinical follow-up recommendations. Both models were able to identify individuals with more than a 2-fold risk increase. The observed 10-year risks of developing melanoma for individuals in the 99th percentile exceeded the risk of individuals in the 1st percentile more than 4.5-fold. We have developed a PRS-based recommendations pipeline for individual health behavior suggestions to support melanoma prevention.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
Nature Communications
4913 papers in training set
Top 17%
10.2%
2
Cancers
200 papers in training set
Top 0.5%
8.5%
3
Pigment Cell & Melanoma Research
11 papers in training set
Top 0.1%
7.3%
4
Scientific Reports
3102 papers in training set
Top 13%
6.9%
5
European Journal of Human Genetics
49 papers in training set
Top 0.1%
6.5%
6
Journal of Medical Genetics
28 papers in training set
Top 0.1%
4.9%
7
European Journal of Cancer
10 papers in training set
Top 0.1%
4.4%
8
JNCI: Journal of the National Cancer Institute
16 papers in training set
Top 0.1%
4.0%
50% of probability mass above
9
Cancer Epidemiology, Biomarkers & Prevention
17 papers in training set
Top 0.1%
3.6%
10
Journal of Investigative Dermatology
42 papers in training set
Top 0.2%
2.8%
11
International Journal of Cancer
42 papers in training set
Top 0.4%
2.8%
12
Genome Medicine
154 papers in training set
Top 4%
1.7%
13
Journal of Translational Medicine
46 papers in training set
Top 1%
1.5%
14
Human Mutation
29 papers in training set
Top 0.4%
1.3%
15
PLOS ONE
4510 papers in training set
Top 58%
1.3%
16
Frontiers in Oncology
95 papers in training set
Top 3%
1.2%
17
Cancer Medicine
24 papers in training set
Top 1.0%
1.2%
18
Frontiers in Genetics
197 papers in training set
Top 7%
1.2%
19
Annals of Oncology
13 papers in training set
Top 0.7%
1.0%
20
The American Journal of Human Genetics
206 papers in training set
Top 3%
1.0%
21
Nature Medicine
117 papers in training set
Top 4%
1.0%
22
PLOS Computational Biology
1633 papers in training set
Top 23%
0.8%
23
eLife
5422 papers in training set
Top 55%
0.8%
24
eBioMedicine
130 papers in training set
Top 3%
0.8%
25
Scientific Data
174 papers in training set
Top 2%
0.8%
26
International Journal of Epidemiology
74 papers in training set
Top 2%
0.8%
27
Science Advances
1098 papers in training set
Top 27%
0.8%
28
eClinicalMedicine
55 papers in training set
Top 2%
0.8%
29
PLOS Medicine
98 papers in training set
Top 5%
0.7%
30
BMC Medical Genomics
36 papers in training set
Top 1%
0.7%